about
In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis.Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice.NAT1 genotypes do not predict response to mesalamine in patients with ulcerative colitis.Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn's disease.Three genes of a motility operon and their role in flagellar rotary speed variation in Rhizobium meliloti.Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation.Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome.Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development.Cathepsin D is up-regulated in inflammatory bowel disease macrophages.Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis.Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression.Succinate receptor mediates intestinal inflammation and fibrosisMonocyte differentiation in intestine-like macrophage phenotype induced by epithelial cellsCell-cell contacts prevent anoikis in primary human colonic epithelial cellsA new organotypic model to study cell interactions in the intestinal mucosaCathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivoGene expression profiles of mucosal fibroblasts from strictured and nonstrictured areas of patients with Crohn's diseaseSphingomyelin induces cathepsin D-mediated apoptosis in intestinal epithelial cells and increases inflammation in DSS colitisThe BH3-mimetic ABT-737 inhibits allogeneic immune responsesBCL-2 levels do not predict azathioprine treatment response in inflammatory bowel disease, but inhibition induces lymphocyte apoptosis and ameliorates colitis in miceBCL2 Regulates Differentiation of Intestinal Fibroblasts
P50
Q34578714-A4507E8F-AE8B-4F95-8555-CF577BE70BF4Q35754002-59EABD55-6CB7-4721-A707-253EB2CA6C6BQ37103300-50110447-E9F2-410D-9A1C-CDD4C9105149Q38325093-391F39A5-95E5-403B-94DD-3B776DD1FAF2Q39847565-40ED82F5-8EDD-41AE-89D0-01B0EB4852ABQ41107802-DFFD2A4B-6BBE-4B15-8941-8F1329A572A1Q41146941-09147114-6C51-4E80-B494-A91E11CEF244Q47144405-049FBE24-6B2B-4C90-957F-946F9337AFB7Q47927170-B5F0D195-25B2-4B03-A503-B67B679130FEQ49106201-D1EE90F6-CC10-4723-9F9E-A9AFB51F9C12Q50743251-37D3F1FC-23CC-4DBD-9AA9-FB3B682EBEF8Q57048573-D15F9962-579E-4841-AB62-7B205BC5A66AQ74330900-75301A94-754C-4F83-8209-F2141B7FA2D1Q79676531-94F3BA73-9D08-4FF1-B14F-708044421342Q79852713-535164A6-8C8D-4045-9229-6746A6B1C892Q80249795-B01B1512-E17C-4058-A51D-A972036106B2Q82225868-B5BA96DF-77F6-47C0-87A8-3093C97D7D45Q82451097-133B2771-1966-40DA-83A0-DBE3AC935B7BQ84201771-F0503DDD-BE36-482F-9F26-E9EE8AB29803Q88624173-1286F914-3301-4EFA-A641-57D26A03FF5BQ88800454-4E633E49-B425-4246-8DF4-65AFCE63BE08
P50
description
researcher
@en
wetenschapper
@nl
name
M Hausmann
@en
M Hausmann
@nl
type
label
M Hausmann
@en
M Hausmann
@nl
prefLabel
M Hausmann
@en
M Hausmann
@nl
P106
P31
P496
0000-0002-0696-0251